SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+4.69%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$864M
AUM Growth
+$864M
(+2.8%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
48.36%
Holding
121
New
34
Increased
19
Reduced
27
Closed
25
Top Buys
| 1 |
Generac Holdings
GNRC
|
$13M |
| 2 |
Johnson & Johnson
JNJ
|
$11.9M |
| 3 |
BioXcel Therapeutics
BTAI
|
$11.7M |
| 4 |
Eli Lilly
LLY
|
$9.77M |
| 5 |
Meta Platforms (Facebook)
META
|
$9.17M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$41.2M |
| 2 |
Novo Nordisk
NVO
|
$26.2M |
| 3 |
Fiverr
FVRR
|
$15.2M |
| 4 |
Nice
NICE
|
$15.2M |
| 5 |
Q32 Bio
QTTB
|
$10M |
Sector Composition
| 1 | Healthcare | 83.14% |
| 2 | Technology | 6.68% |
| 3 | Consumer Discretionary | 3.03% |
| 4 | Industrials | 2.58% |
| 5 | Communication Services | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immatics
IMTX
$619M
| $8.49M | 0.83% | +800,000 | New | +$8.49M |
|
27
Iovance Biotherapeutics
IOVA
$807M
| $8.33M | 0.82% | 253,000 -95,000 | -27% | -$3.13M |
|
28
JFrog
FROG
$5.76B
| $8.08M | 0.79% | +95,415 | New | +$8.08M |
|
|
29
Fiverr
FVRR
$870M
| $7.96M | 0.78% | 57,301 -109,701 | -66% | -$15.2M |
|
30
Krystal Biotech
KRYS
$4.27B
| $7.95M | 0.78% | 184,573 +40,000 | +28% | +$1.72M |
|
31
Wave Life Sciences
WVE
$1.53B
| $7.91M | 0.78% | 931,200 +638,200 | +218% | +$5.42M |
|
32
Repare Therapeutics
RPTX
$71.7M
| $7.54M | 0.74% | 245,000 | – | – |
|
33
Syndax Pharmaceuticals
SNDX
$1.41B
| $7.53M | 0.74% | 510,000 +290,000 | +132% | +$4.28M |
|
34
Fate Therapeutics
FATE
$120M
| $7.51M | 0.74% | 188,000 -37,000 | -16% | -$1.48M |
|
35
Fiserv
FI
$75.1B
| $7.24M | 0.71% | 70,246 -25,000 | -26% | -$2.58M |
|
36
Burlington
BURL
$18.3B
| $7.21M | 0.71% | +35,000 | New | +$7.21M |
|
37
Varonis Systems
VRNS
$6.61B
| $6.95M | 0.68% | +60,225 | New | +$6.95M |
|
38
Domino's
DPZ
$15.6B
| $6.9M | 0.68% | 16,221 +1,700 | +12% | +$723K |
|
39
ALX Oncology
ALXO
$62.7M
| $6.87M | 0.68% | +182,070 | New | +$6.87M |
|
40
Zentalis Pharmaceuticals
ZNTL
$122M
| $6.37M | 0.63% | +194,996 | New | +$6.37M |
|
|
VRNA
41
Verona Pharma
VRNA
$9.16B
| $6.24M | 0.61% | +1,000,000 | New | +$6.24M |
|
42
iTeos Therapeutics
ITOS
| $6.17M | 0.61% | +250,000 | New | +$6.17M |
|
43
Immunovant
IMVT
$2.56B
| $5.98M | 0.59% | 170,000 +65,000 | +62% | +$2.29M |
|
|
ALBO
44
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $5.79M | 0.57% | +173,600 | New | +$5.79M |
|
|
RETA
45
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.76M | 0.57% | 59,139 -22,910 | -28% | -$2.23M |
|
|
ARNA
46
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.61M | 0.55% | +75,000 | New | +$5.61M |
|
|
ARYBU
47
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
| $5.49M | 0.54% | 499,000 +199,000 | +66% | +$2.19M |
|
48
Celldex Therapeutics
CLDX
$1.47B
| $5.49M | 0.54% | +370,000 | New | +$5.49M |
|
|
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.48M | 0.54% | 33,000 -39,000 | -54% | -$6.48M |
|
|
SIOX
50
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.33M | 0.52% | 1,152,998 -1,705,000 | -60% | -$7.88M |
|